| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 1,525 | 1,525 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 500 Shares Abbvie | 14,217 | 88,850 |
| 400 Shares Amgen | 0 | 0 |
| 1500 Shares Pfizer | 25,420 | 39,795 |
| 400 Share Verizon | 13,112 | 15,996 |
| 350 Shares Amgen | 21,498 | 91,224 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Other Expenses | 50 | 50 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| UBS-Account Statement | 1,446 | 1,446 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Taxes Paid | 200 | 200 | 0 | 0 |